Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

JOURNAL ARTICLE published 27 May 2021 in Frontiers in Oncology

Authors: Saeka Egami | Hitoshi Kawazoe | Hironobu Hashimoto | Ryuji Uozumi | Toko Arami | Naomi Sakiyama | Yuichiro Ohe | Hideo Nakada | Tohru Aomori | Shinnosuke Ikemura | Koichi Fukunaga | Masakazu Yamaguchi | Tomonori Nakamura